Reduction in activating transcription factor 4 promotes carbon tetrachloride and lipopolysaccharide/D‑galactosamine‑mediated liver injury in mice

Mol Med Rep. 2018 Aug;18(2):1718-1725. doi: 10.3892/mmr.2018.9080. Epub 2018 May 29.

Abstract

Although activating transcription factor 4 (ATF4) is involved in the regulation of numerous biological functions, whether ATF4 has a direct role in liver injury is unknown. The aim of the present study was to investigate the role of ATF4 in liver injury using mouse models. The results revealed that ATF4 protein is expressed markedly higher in the mouse liver when in comparison with other tissues. Notably, tunicamycin treatment, an endoplasmic reticulum (ER) stress inducer, induced the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), but decreased ATF4 protein levels in the mouse liver. This suggested an unconventional regulation pattern of ATF4 protein not associated with ER stress or eIF2α. In addition, it was also observed that the liver levels of ATF4 protein were significantly reduced upon chronic liver injury induced by carbon tetrachloride (CCl4). ATF4 protein was also decreased in acute liver injury induced by lipopolysaccharide (LPS) plus D‑galactosamine (D‑GalN). Furthermore, the results revealed that knockdown of ATF4 by injecting ATF4‑targeting Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)‑CRISPR associated protein 9 plasmids exacerbated CCl4 and LPS/D‑GalN‑induced liver injury as demonstrated by elevated serum aspartate transaminase and alanine aminotransferase levels. ATF4 suppression also enhanced CCl4 and LPS/D‑GalN mediated c‑Jun N‑terminal kinase activation. By contrast, ATF4 overexpression alleviated CCl4 and LPS/D‑GalN‑induced liver injury. Taken together, these observations suggested that ATF4 may serve a protective role in the mouse liver.

MeSH terms

  • Activating Transcription Factor 4 / genetics*
  • Activating Transcription Factor 4 / metabolism
  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • CRISPR-Cas Systems
  • Carbon Tetrachloride / administration & dosage*
  • Chemical and Drug Induced Liver Injury / genetics*
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / pathology
  • Endoplasmic Reticulum Stress / drug effects
  • Eukaryotic Initiation Factor-2 / genetics
  • Eukaryotic Initiation Factor-2 / metabolism
  • Galactosamine / administration & dosage*
  • Gene Editing
  • Gene Expression Regulation
  • JNK Mitogen-Activated Protein Kinases / genetics
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lipopolysaccharides / administration & dosage*
  • Liver / drug effects
  • Liver / metabolism*
  • Liver / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Phosphorylation
  • Plasmids / chemistry
  • Plasmids / metabolism
  • Protective Factors
  • Tunicamycin / pharmacology

Substances

  • Atf4 protein, mouse
  • Eukaryotic Initiation Factor-2
  • Lipopolysaccharides
  • Tunicamycin
  • Activating Transcription Factor 4
  • Galactosamine
  • Carbon Tetrachloride
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • JNK Mitogen-Activated Protein Kinases